Omni Active Health to invest Rs. 150 cr in acquisitions over 3-4 years.

OmniActive Health Technologies, a leading nutraceutical company, is looking at more strategic acquisitions in domestic and foreign markets and has drawn up capital expenditure plans of around Rs. 150 crore in the next three years.

Building on an M&A (mergers and acquisitions) strategy to grow inorganically, the company has recently acquired leading health and nutrition active natural ingredient player, Indfrag.

'We are now looking at more strategic acquisitions in the domestic as well as foreign markets in the space of marketing and technology,' OmniActive MD Sanjaya Mariwala told PTI.

The company's strength lies in its ability to leverage science and technology to meet consumer demand and rigorous quality standards for today's dietary supplement market.

In the last 18 months, OmniActive completed 12 human clinical trials with healthy population across its portfolio of branded ingredients, providing unique, science-based claims to expand consumer offerings.

'We are continuously making an investment in R&D and expansion programmes. We are doing a capex of Rs 30-35 crore per annum and going forward, looking at an investment of around Rs 150 crore for expansion of more nutraceutical products', Mariwala said.

BS